Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models

Autor:	Buocikova, Verona, Longhin, Eleonora Marta, Pilalis, Eleftherios, Mastrokalou, Chara, Miklikova, Svetlana, Cihova, Marina, Poturnayova, Alexandra, Mackova, Katarina, Babelova, Andrea, Trnkova, Lenka, El Yamani, Naouale, Zheng, Congying, Rios-Mondragon, Ivan, Labudova, Martina, Csaderova, Lucia, Kuracinova, Kristina Mikus, Makovicky, Peter, Kucerova, Lucia, Matuskova, Miroslava, Cimpan, Mihaela Roxana, Dusinska, Maria, Babal, Pavel, Chatziioannou, Aristotelis, Gabelova, Alena, Rundén-Pran, Elise, Smolkova, Bozena
Zdroj:	In Biomedicine & Pharmacotherapy March 2022 147
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect